• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Great Post on BMS Board

Anonymous

Guest
Re: Eliquis launch comment

--------------------------------------------------------------------------------

This single launch did two things:

1. Highlight BMS' inability to sell
2. Put to death the myth that Pfizer reps are great

Single best drug for each company in over a decade, best in class data, last in class usage.

Pitiful.
 

<



Re: Eliquis launch comment

--------------------------------------------------------------------------------

This single launch did two things:

1. Highlight BMS' inability to sell
2. Put to death the myth that Pfizer reps are great

Single best drug for each company in over a decade, best in class data, last in class usage.

Pitiful.

We'll see who the pitiful one truly is, once Pradaxa is forced to withdraw from the market.

Dumbass.